Hidaka-shi

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Lung cancer

Closed trials

• Completed

  An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)

  NCT02477826· Phase 3· Bristol-Myers Squibb· Source